Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Hologic, Inc.
< Previous
1
2
3
Next >
Hologic Ranked #1 for Mammography System Performance and Customer Satisfaction for 10th Consecutive Year
December 01, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic to Showcase Portfolio of Comprehensive Breast and Skeletal Health Solutions at RSNA 2022
November 25, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic to Webcast Presentation at the 5th Annual Evercore ISI HealthCONx Conference
November 22, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic Announces Contract with BARDA to Support IVD Approval of COVID Assays
November 02, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2022
October 31, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2022 on Monday, October 31, 2022
October 04, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic Rings Nasdaq Opening Bell to Kick Off Breast Cancer Awareness Month
October 03, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
More than 1.5 Billion Women Worldwide Lack Essential Health Screenings
September 21, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic to Webcast Presentations at Upcoming Investor Conferences
August 30, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic and Mary J. Blige Launch “Good Morning Gorgeous” Sweepstakes as a Wake-up Call to Increase Awareness of the Importance of Preventive Care
August 12, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
U.S. Court of Appeals for the Federal Circuit Affirms 2018 Ruling Barring Minerva from Challenging Hologic’s Patent Rights
August 11, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic Announces Financial Results for Third Quarter of Fiscal 2022
July 27, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2022 on Wednesday, July 27, 2022
July 05, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
New Survey Reveals Lack of Knowledge among U.S. Women about Uterine Health, Including Fibroid Symptoms and Treatment Options
July 01, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic Board Member, Sally W. Crawford, Recognized As NACD Directorship 100™ Honoree
May 17, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic Announces FDA Approval of Aptima® CMV Quant Assay for Human Cytomegalovirus
May 10, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic to Webcast Presentation at Upcoming Investor Conference
May 04, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic Announces Financial Results for Second Quarter of Fiscal 2022
April 27, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Now Includes Breast Cancer Index™ to Guide Decisions about Extended Endocrine Therapy
April 25, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2022 on Wednesday, April 27, 2022
April 04, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic to Webcast Presentations at Upcoming Investor Conferences
February 15, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic Announces Financial Results for First Quarter of Fiscal 2022
February 02, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic Launches First-Ever National Advertising Campaign Featuring Mary J. Blige
February 01, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic’s Sustainability Leadership Makes Company “A Global Force for Good”
January 24, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2022
January 09, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic to Announce Financial Results for the First Quarter of Fiscal 2022 on Wednesday, February 2, 2022
January 05, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic Adds Aptima SARS-CoV-2 Assay to its Global Access Initiative in Resource-Limited Countries
January 05, 2022
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic to Webcast Presentation at the 40th Annual J.P. Morgan Healthcare Conference
December 28, 2021
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic Launches Panther Trax for High Volume Molecular Testing
December 23, 2021
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
Hologic Presents Breast Cancer Index™ Data at SABCS 2021 Showing Net Benefit Predictive Value for Endocrine Therapy Continuation
December 10, 2021
From
Hologic, Inc.
Via
Business Wire
Tickers
HOLX
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.